肇民科技(301000.SZ):目前積極與客户共同開發人形機器人精密零部件新品
格隆匯7月4日丨有投資者於投資者互動平台向肇民科技(301000.SZ)提問,“貴公司在精密功能注塑領域有很豐富的經驗和海外業務,請問是否關注到人形機器人領域和智能家電領域?”,公司回覆稱,公司的產品聚焦於乘用車、商用車、新能源車、高端廚衞家電等領域,公司生產的家用電器用精密注塑件主要為智能座便器、家用熱水器、家用淨水器等廚衞家用電器的核心功能件。人形機器人領域,公司目前積極與客户共同開發人形機器人精密零部件新品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.